Honor Charlotte Murdoff through #10forChar! 🦋 Follow @osinstitute on Instagram for stories from her friends and siblings. Learn more or give in Char’s memory: https://t.co/mPyL92y8JR
We're hiring! OSI is seeking a Director of Scientific Programs to help advance osteosarcoma research and bring new treatments to patients faster. This is the first of two new roles as our team grows!
Apply by Dec. 15: https://t.co/TpWFqKPzmU
This November's #OSI10for10 honors Charlotte Murdoff through 10 for Char! Visit our Instagram (@osinstitute) for 10 days of stories from her friends and siblings. Learn more or give in Char’s memory: https://t.co/mPyL92y8JR
Breakthroughs in #osteosarcomaresearch require sustained investment over time and partnerships with stakeholders all along the lab-to-patient path. Discover how OSI is accelerating research: https://t.co/J32B4gXR84
Metastatic osteosarcoma occurs when bone cancer spreads from its original location to other parts of the body. It’s harder to fight, but researchers are working hard to find better treatments. Learn more: https://t.co/2qIDVbqG5t
Thank you for participating in the first month of #OSI10for10! Your support makes #osteosarcoma research possible, including a multi-center trial studying lung surgery in dogs to generate insights that will improve treatment for canine and human patients. https://t.co/I9nN5PyHkC
OSI and @TheMarkFdn brought together 25 researchers in Dallas to explore new immunotherapy strategies for osteosarcoma. As the next step in this initiative, multi-million-dollar funding is planned to support collaborative projects emerging from the workshop.
Thank you to @OSInstitute and @TheMarkFdn for the invitation this weekend at the IO summit for #osteosarcoma. Tremendous opportunity to identify opportunities for collaboration. I learned so much from you all. @PatrickHwuMD
We need better therapies for #osteosarcoma, and that starts with bringing brilliant minds together. Grateful to @TheMarkFdn and @OSInstitute for convening such an outstanding group of investigators to challenge assumptions, spark new ideas and advance hope for patients who urgently need better treatments.
A huge thank you to Richard Gorlick, Catherine Bollard, and Patrick Hwu for bringing together an outstanding group of scientists and clinicians and leading two days of deep dives into the data, spirited debate, and new connections. Excited to see the ideas and collaborations that emerge!
We've had two thrilling days in Dallas gathering the scientific community for Advancing Immunotherapy for Osteosarcoma, organized with @OSInstitute. The challenges are immense, but so is the potential. Together, we're working toward better treatments for patients who urgently need them.
Diagnosed with osteosarcoma at 15, Anthony was given five years to live. Six years later, he’s had no evidence of disease for two years, he is turning 21, and he is helping other families navigate cancer.
Read more: https://t.co/sZ0nElMfss
#OSI10for10 has officially begun! The 10 for 10 Campaign aims to raise $10 million to advance promising science and deliver safer, more effective treatments for patients. Give now and your gift will be doubled: https://t.co/I9nN5PyHkC
Today, OSI launches the 10 for 10 Campaign to advance promising science and move new osteosarcoma treatments closer to patients. Our first giving opportunity drops later today. #OSI10for10 https://t.co/I9nN5PyHkC
Take osteosarcoma advocacy to the next level and become an OSI Ambassador! Sign up for a free webinar on Tuesday, 10/13, 6 p.m. CT, or Monday, 11/16, 5 p.m. CT to learn more. https://t.co/GeRn5AyIb6
BIG announcement is coming in 10 days. Check back here on October 10 to discover where we’re going in the next decade and how you can join us in the journey. https://t.co/kqXiouzpR7
After an osteosarcoma diagnosis, things move fast, including decisions about surgery. Read our guide to surgical options for primary tumor removal and lung surgery, with insights from two leading surgeons: https://t.co/EoCkgHmiNK
We’re gearing up for a big announcement. For 10 years, OSI has funded the most promising osteosarcoma science. In October, discover where we’re going in the next decade, and learn how you can join us in the journey. https://t.co/kqXiouzpR7
Join our final free planned giving webinar of 2026! Join us Tuesday, 9/15 at 11:30 a.m. CDT, and learn how to support osteosarcoma research through wills, investment funds, and more. Sign up: https://t.co/fIA17hVJxh
📆 Calling all osteosarcoma researchers! Don’t forget to submit your Letter of Intent for OSI’s 2026-2027 Grant Cycle. Deadline is Thursday, September 10, at 12:00 p.m. ET. Learn more: https://t.co/zvb604GOrT